JILL M REESE

Physician Assistants & Advanced Practice Nursing Providers|Clinical Nurse Specialist|Oncology BEAVERCREEK, OH NPI 1194246009

General Payments — all program years on this page

$6,879.55

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 95
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,637.08 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $195.904
2022 $770.4826
2023 $4,276.0947
2024 $1,637.0818

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089473543 Daiichi Sankyo Inc. $15.00 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101158122 Celgene Corporation $16.84 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101577163 E.R. Squibb & Sons, L.L.C. $121.97 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104205437 AstraZeneca Pharmaceuticals LP $16.45 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104515554 AstraZeneca Pharmaceuticals LP $81.48 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114361296 Regeneron Healthcare Solutions, Inc. $21.52 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114361298 Regeneron Healthcare Solutions, Inc. $21.90 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114361300 Regeneron Healthcare Solutions, Inc. $6.75 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114361302 Regeneron Healthcare Solutions, Inc. $929.00 07/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1114361304 Regeneron Healthcare Solutions, Inc. $76.50 08/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114361306 Regeneron Healthcare Solutions, Inc. $22.78 09/12/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1130972101 PFIZER INC. $16.70 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135710078 Lilly USA, LLC $20.92 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139525808 Astellas Pharma US Inc $124.99 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141250728 Incyte Corporation $13.78 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141317219 Incyte Corporation $20.63 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148990034 Sumitomo Pharma America, Inc. $17.49 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151298020 JAZZ PHARMACEUTICALS INC. $92.38 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.